Dhruv Bansal
Experienced in Appendix Cancer

Dr. Dhruv Bansal

Oncology
Endeavor Health
Endeavor Health Medical Group
2650 Ridge Ave., Kellogg Cancer Center, 
Evanston, IL 
14 Years of Experience

Experienced in Appendix Cancer
Endeavor Health
Endeavor Health Medical Group
2650 Ridge Ave., Kellogg Cancer Center, 
Evanston, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dhruv Bansal, MD, a hematology and oncology specialist at Endeavor Health, provides care for patients with blood disorders and cancer. With more than a decade of clinical experience, Dr. Bansal offers evidence-based treatment plans tailored to each patient’s diagnosis and needs. He works closely with multidisciplinary teams to support patients through every stage of care, from diagnosis to survivorship.

Dr. Bansal is rated as an Experienced provider by MediFind in the treatment of Appendix Cancer. His top areas of expertise are Lung Adenocarcinoma, Colorectal Cancer, ALK-Positive Non-Small Cell Lung Cancer, and Squamous Cell Lung Carcinoma.

His clinical research consists of co-authoring 20 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Smt. NHL Municipal Medical College, 2006
Residency
University of New Mexico Hosp BCMC, Internal Medicine, 2011
Specialties
Oncology
Licenses
Internal Medicine in MO
Board Certifications
American Board Of Internal Medicine
Fellowships
Loma Linda University Medical Center (ED), Medical Oncology, 2019
Washington University in St. Louis School of Medicine, Hematology/Oncology, 2021
Hospital Affiliations
Swedish Hospital
Northshore University Healthsystem - Evanston Hospital
Saint Luke's East Hospital
Saint Luke's South Hospital
St Lukes Hospital Of Kansas City
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Endeavor Health Medical Group
2650 Ridge Ave., Kellogg Cancer Center, Evanston, IL 60201
Call: 847-570-2112
Other Locations
Endeavor Health Medical Group
2180 Pfingsten Rd., Kellogg Cancer Center, Glenview, IL 60026
Call: 847-503-1000
Endeavor Health Medical Group
757 Park Ave. West, Kellogg Cancer Center, Highland Park, IL 60035
Call: 847-570-2112

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


2 Clinical Trials

Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study
Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study
Enrollment Status: Active_not_recruiting
Publish Date: January 26, 2026
Intervention Type: Other, Drug
Study Drugs: Oxaliplatin, Duloxetine Hydrochloride, Duloxetine
Study Phase: Phase 2/Phase 3
A Phase 1b Clinical Trial of Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)
A Phase 1b Clinical Trial of Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)
Enrollment Status: Completed
Publish Date: November 12, 2025
Intervention Type: Drug, Procedure
Study Drugs: Cabozantinib, Nivolumab, Abiraterone, Prednisone
Study Phase: Phase 1
View 1 Less Clinical Trial

20 Total Publications

Immune checkpoint inhibitor-induced hemophagocytic lymphohistiocytosis in lung cancer: a case series.
Immune checkpoint inhibitor-induced hemophagocytic lymphohistiocytosis in lung cancer: a case series.
Journal: Exploration of targeted anti-tumor therapy
Published: April 19, 2025
View All 20 Publications
Similar Doctors
Elite in Appendix Cancer
Dr. Blase N. Polite
Oncology | Hematology
Elite in Appendix Cancer
Dr. Blase N. Polite
Oncology | Hematology

The University Of Chicago Medical Center

5841 S Maryland Ave, 
Chicago, IL 
 (19.5 miles away)
773-702-1000
Languages Spoken:
English, Mandarin
See accepted insurances
Accepting New Patients
Offers Telehealth

Blase Polite is an Oncologist and a Hematologist in Chicago, Illinois. Dr. Polite is rated as an Elite provider by MediFind in the treatment of Appendix Cancer. His top areas of expertise are Colorectal Cancer, Appendix Cancer, Familial Colorectal Cancer, Gastrostomy, and Colonoscopy. Dr. Polite is currently accepting new patients.

Elite in Appendix Cancer
Dr. Ardaman K. Shergill
Oncology | Hematology
Elite in Appendix Cancer
Dr. Ardaman K. Shergill
Oncology | Hematology

The University Of Chicago Medical Center

5841 S Maryland Ave, 
Chicago, IL 
 (19.5 miles away)
773-702-1000
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ardaman Shergill is an Oncologist and a Hematologist in Chicago, Illinois. Dr. Shergill has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Appendix Cancer. Her top areas of expertise are Appendix Cancer, Colorectal Cancer, Anal Cancer, and Familial Pancreatic Cancer. Dr. Shergill is currently accepting new patients.

Distinguished in Appendix Cancer
Dr. Chih-yi '. Liao
Hematology Oncology | Hematology | Oncology
Distinguished in Appendix Cancer
Dr. Chih-yi '. Liao
Hematology Oncology | Hematology | Oncology

The University Of Chicago Medical Center

5841 S Maryland Ave, 
Chicago, IL 
 (19.5 miles away)
773-702-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Chih-yi Liao is a Hematologist Oncology specialist and a Hematologist in Chicago, Illinois. Dr. Liao is rated as a Distinguished provider by MediFind in the treatment of Appendix Cancer. His top areas of expertise are Neuroendocrine Tumor, Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Hepatectomy, and Gastrostomy. Dr. Liao is currently accepting new patients.

VIEW MORE APPENDIX CANCER DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bansal's expertise for a condition
ConditionClose
    • Distinguished
    • Lung Adenocarcinoma
      Dr. Bansal is
      Distinguished
      . Learn about Lung Adenocarcinoma.
      See more Lung Adenocarcinoma experts
    • Advanced
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Bansal is
      Advanced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Colorectal Cancer
      Dr. Bansal is
      Advanced
      . Learn about Colorectal Cancer.
      See more Colorectal Cancer experts
    • EGFR Positive Lung Cancer
      Dr. Bansal is
      Advanced
      . Learn about EGFR Positive Lung Cancer.
      See more EGFR Positive Lung Cancer experts
    • Familial Colorectal Cancer
      Dr. Bansal is
      Advanced
      . Learn about Familial Colorectal Cancer.
      See more Familial Colorectal Cancer experts
    • Lung Cancer
      Dr. Bansal is
      Advanced
      . Learn about Lung Cancer.
      See more Lung Cancer experts
    • Non-Small Cell Lung Cancer (NSCLC)
      Dr. Bansal is
      Advanced
      . Learn about Non-Small Cell Lung Cancer (NSCLC).
      See more Non-Small Cell Lung Cancer (NSCLC) experts
    View All 9 Advanced Conditions
    • Experienced
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Bansal is
      Experienced
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Bansal is
      Experienced
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Acute Myeloid Leukemia (AML)
      Dr. Bansal is
      Experienced
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    • Adult Soft Tissue Sarcoma
      Dr. Bansal is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Adult T-Cell Leukemia
      Dr. Bansal is
      Experienced
      . Learn about Adult T-Cell Leukemia.
      See more Adult T-Cell Leukemia experts
    • Ampullary Cancer
      Dr. Bansal is
      Experienced
      . Learn about Ampullary Cancer.
      See more Ampullary Cancer experts
    View All 32 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.